We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.35B
AUM Growth
-$265M
(-5.7%)
Cap. Flow
-$308M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
16.54%
Holding
629
New
5
Increased
18
Reduced
506
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.19M |
| 2 |
Medtronic
MDT
|
+$6.17M |
| 3 |
Qorvo
QRVO
|
+$3.05M |
| 4 |
Alkermes
ALKS
|
+$3M |
| 5 |
Comcast
CMCSA
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$15M |
| 2 |
Apple
AAPL
|
+$12.4M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$11M |
| 4 |
ExxonMobil
XOM
|
+$5.57M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 15.07% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Phillips 66
PSX
$84.9B
| $9.77M | 0.22% |
124,255
-9,953
| -7% | -$731K |
|
|
APC
102
DELISTED
Anadarko Petroleum
APC
| $9.39M | 0.22% |
113,342
-6,867
| -6% | -$562K |
|
103
Elevance Health
ELV
$81.5B
| $9.38M | 0.22% |
60,745
-5,169
| -8% | -$736K |
|
104
Dominion Energy
D
$60.8B
| $9.15M | 0.21% |
129,070
-9,471
| -7% | -$703K |
|
105
Automatic Data Processing
ADP
$106B
| $9.11M | 0.21% |
106,351
-8,409
| -7% | -$724K |
|
|
TFCFA
106
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $9.1M | 0.21% |
267,733
-30,483
| -10% | -$1.06M |
|
|
YHOO
107
DELISTED
Yahoo Inc
YHOO
| $9.02M | 0.21% |
203,047
-22,921
| -10% | -$1.04M |
|
108
Salesforce
CRM
$151B
| $9.02M | 0.21% |
134,966
-7,814
| -5% | -$485K |
|
|
DTV
109
DELISTED
DIRECTV COM STK (DE)
DTV
| $8.92M | 0.21% |
104,841
-8,117
| -7% | -$701K |
|
110
Kimberly-Clark
KMB
$36.3B
| $8.85M | 0.2% |
82,630
-6,871
| -8% | -$759K |
|
111
American Tower
AMT
$80.8B
| $8.8M | 0.2% |
93,430
-1,795
| -2% | -$175K |
|
112
Southern Company
SO
$109B
| $8.75M | 0.2% |
197,611
-17,822
| -8% | -$847K |
|
113
Emerson Electric
EMR
$83.9B
| $8.64M | 0.2% |
152,627
-13,296
| -8% | -$773K |
|
114
Cognizant
CTSH
$24.9B
| $8.62M | 0.2% |
138,217
-8,310
| -6% | -$490K |
|
115
LyondellBasell Industries
LYB
$20B
| $8.42M | 0.19% |
95,933
-8,915
| -9% | -$750K |
|
116
Baxter International
BAX
$13.5B
| $8.34M | 0.19% |
224,149
-16,460
| -7% | -$624K |
|
|
AET
117
DELISTED
Aetna Inc
AET
| $8.34M | 0.19% |
78,284
-5,899
| -7% | -$578K |
|
118
Halliburton
HAL
$26.9B
| $8.32M | 0.19% |
189,539
-14,992
| -7% | -$625K |
|
119
Regeneron Pharmaceuticals
REGN
$78.5B
| $8.28M | 0.19% |
18,334
-825
| -4% | -$350K |
|
120
Williams Companies
WMB
$87.5B
| $8.26M | 0.19% |
163,295
-10,302
| -6% | -$478K |
|
121
Chubb
CB
$135B
| $8.19M | 0.19% |
73,061
-7,311
| -9% | -$822K |
|
122
Prudential Financial
PRU
$42.4B
| $8.09M | 0.19% |
100,695
-7,987
| -7% | -$647K |
|
|
SCHW
123
Charles Schwab
SCHW
$183B
| $8.01M | 0.18% |
263,156
-20,335
| -7% | -$589K |
|
124
Travelers Companies
TRV
$78.1B
| $7.95M | 0.18% |
73,510
-7,420
| -9% | -$792K |
|
|
LNKD
125
DELISTED
LinkedIn Corporation
LNKD
| $7.94M | 0.18% |
31,789
-1,639
| -5% | -$407K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q1 2015 Portfolio in Review
As of Q1 2015, Fjarde Ap-fonden held 629 positions worth $4.35B, down 5.7% from $4.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fjarde Ap-fonden withdrew a net $308M in Q1 2015, closing 10 positions and reducing 506 holdings. Its most notable exit was Allergan Inc, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Fjarde Ap-fonden opened a new position in Qorvo worth $3.42M.
- Fjarde Ap-fonden's largest Q1 2015 buy was Qorvo: 42,872 shares worth $3.42M.
- Fjarde Ap-fonden added most to Allergan plc in Q1 2015, an estimated $6.19M increase.
- Fjarde Ap-fonden's biggest Q1 2015 reduction was Apple, cutting an estimated $12.4M.
- Fjarde Ap-fonden fully exited Allergan Inc in Q1 2015, selling an estimated $15M.
- Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.35B portfolio in Q1 2015.
- Fjarde Ap-fonden opened 5 new positions and closed 10 in Q1 2015.
- Fjarde Ap-fonden's portfolio value fell 5.7% quarter-over-quarter to $4.35B.
Based on Fjarde Ap-fonden's 13F filing for Q1 2015, filed 13 Apr 2015.